Literature DB >> 3793867

Cytotoxic and enterotoxic activities of Campylobacter jejuni are not specified by tetracycline resistance plasmids pMAK175 and pUA466.

D E Taylor, W M Johnson, H Lior.   

Abstract

The 45-kilobase tetracycline resistance plasmids pMAK175 and pUA466 from Campylobacter jejuni were examined using curing and mating experiments. However, these plasmids encoded neither cytotoxin production, as determined in Vero cells, nor enterotoxin activity, as determined in Chinese hamster ovary cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3793867      PMCID: PMC265844          DOI: 10.1128/jcm.25.1.150-151.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant.

Authors:  D E Taylor
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

Review 2.  Pathophysiology of Campylobacter enteritis.

Authors:  R I Walker; M B Caldwell; E C Lee; P Guerry; T J Trust; G M Ruiz-Palacios
Journal:  Microbiol Rev       Date:  1986-03

3.  Toxins produced by Campylobacter jejuni and Campylobacter coli.

Authors:  W M Johnson; H Lior
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

4.  Transmissible tetracycline resistance in Campylobacter jejuni.

Authors:  D E Taylor; S A DeGrandis; M A Karmali; P C Fleming
Journal:  Lancet       Date:  1980-10-11       Impact factor: 79.321

5.  Survey of plasmids and resistance factors in Campylobacter jejuni and Campylobacter coli.

Authors:  F C Tenover; S Williams; K P Gordon; C Nolan; J J Plorde
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

6.  Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada.

Authors:  D E Taylor; N Chang; R S Garner; R Sherburne; L Mueller
Journal:  Can J Microbiol       Date:  1986-01       Impact factor: 2.419

7.  Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.

Authors:  D E Taylor; L K Ng; H Lior
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

8.  Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli.

Authors:  D E Taylor; R S Garner; B J Allan
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

9.  Properties of crude Campylobacter jejuni heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations.

Authors:  F A Klipstein; R F Engert; H Short; E A Schenk
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

View more
  1 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.